Literature DB >> 15871023

[Correlation between glaucomatous hemifield scotomas and measurements of nerve fiber layer thickness using scanning laser polarimetry].

P O Denk1, M Markovic, M Knorr.   

Abstract

BACKGROUND: The purpose of the present study was to investigate wether a reduction of the retinal nerve fiber layer (RNFL) in patients with hemifield scotoma can be measured with scanning laser polarimetry and wether regional RNFL parameters can be correlated with the corresponding visual field indices. PATIENTS AND METHODS: We included one eye from each of 40 normal subjects and one eye from each of 40 glaucoma patients. Automated perimetry was performed and the RNFL was analyzed.
RESULTS: HMD values obtained by white-white (W/W) and blue-yellow (B/Y) perimetry failed to correlate significantly with most of the corresponding RNFL parameters obtained with the GDx. Significant correlations were only shown for the inferior HMD (W/W and B/Y) and the superior ratio, superior average, and deviation superior. Furthermore, we found a high correlation between differences of upper and lower GDx parameters and differences of upper and lower visual field indices of W/W and B/Y perimetry.
CONCLUSIONS: Scanning laser polarimetry can detect differences in RNFL sectors in patients with functional hemifield differences and carries the potential to detect changes in RNFL thickness at an early stage.

Entities:  

Mesh:

Year:  2005        PMID: 15871023     DOI: 10.1007/s00347-005-1211-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma.

Authors:  Michael J Greaney; Douglas C Hoffman; David F Garway-Heath; Mamdouh Nakla; Anne L Coleman; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

2.  Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph.

Authors:  L M Zangwill; C Bowd; C C Berry; J Williams; E Z Blumenthal; C A Sánchez-Galeana; C Vasile; R N Weinreb
Journal:  Arch Ophthalmol       Date:  2001-07

3.  Progressive color visual field loss in glaucoma.

Authors:  P A Sample; R N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

4.  The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting.

Authors:  N T Choplin; D C Lundy
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

5.  The concept of visual field indices.

Authors:  J Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

6.  [Laser scanning topography and polarimetry with implantation of intraocular lenses before and after cataract surgery].

Authors:  S Kremmer; A Pflug; A Heiligenhaus; F Fanihagh; K P Steuhl
Journal:  Klin Monbl Augenheilkd       Date:  1999-06       Impact factor: 0.700

7.  Effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry.

Authors:  D S Greenfield; R W Knighton; X R Huang
Journal:  Am J Ophthalmol       Date:  2000-06       Impact factor: 5.258

8.  Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry.

Authors:  C A Johnson; A J Adams; E J Casson; J D Brandt
Journal:  Arch Ophthalmol       Date:  1993-05

9.  Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

Authors:  A Sommer; J Katz; H A Quigley; N R Miller; A L Robin; R C Richter; K A Witt
Journal:  Arch Ophthalmol       Date:  1991-01

10.  [Correlation between glaucomatous hemifield scotomas in white-on-white perimetry and blue-on-yellow perimetry using the oculus twinfield perimeter].

Authors:  P Oliver Denk; Maja Markovic; Marcus Knorr
Journal:  Klin Monbl Augenheilkd       Date:  2004-02       Impact factor: 0.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.